Cardinal Health, Inc [CAH] stock is trading at $207.37, up 1.06%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CAH shares have gain 4.79% over the last week, with a monthly amount drifted -1.01%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cardinal Health, Inc [NYSE: CAH] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $243. Previously, Wells Fargo upgraded its rating to Overweight on June 03, 2025, and kept the price target unchanged to $179. On February 05, 2025, upgrade upgraded it’s rating to Buy and revised its price target to $150 on the stock. TD Cowen upgraded its rating to a Buy and increased its price target to $144 on January 08, 2025. Evercore ISI upgraded its rating to a Outperform but $140 remained the price target by the analyst firm on January 07, 2025. BofA Securities upgraded its rating to Buy for this stock on January 06, 2025, and upped its price target to $145. In a note dated December 13, 2024, Wells Fargo upgraded an Equal Weight rating on this stock and boosted its target price from $101 to $127.
Cardinal Health, Inc [CAH] stock has fluctuated between $116.69 and $214.93 over the past year. Currently, Wall Street analysts expect the stock to reach $215 within the next 12 months. Cardinal Health, Inc [NYSE: CAH] shares were valued at $207.37 at the most recent close of the market. An investor can expect a potential return of 3.68% based on the average CAH price forecast.
Analyzing the CAH fundamentals
Cardinal Health, Inc [NYSE:CAH] reported sales of 234.31B for the trailing twelve months, which represents a growth of 22.44%. Gross Profit Margin for this corporation currently stands at 0.04% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is -0.55 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 205.15 points at the first support level, and at 202.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 208.75, and for the 2nd resistance point, it is at 210.12.
Ratios To Look Out For
For context, Cardinal Health, Inc’s Current Ratio is 0.96. In addition, the Quick Ratio stands at 0.52 and the Cash Ratio stands at 0.11. Considering the valuation of this stock, the price to sales ratio is 0.21 and price to earnings (TTM) ratio is 31.30.
Transactions by insiders
Recent insider trading involved WEITZMAN DEBORAH, Officer, that happened on Aug 20 ’25 when 21367.0 shares were purchased. CEO, PSS Segment, WEITZMAN DEBORAH completed a deal on Aug 20 ’25 to sell 21367.0 shares. Meanwhile, Chief Executive Officer Hollar Jason M. sold 35901.0 shares on Aug 20 ’25.
